ketoconazole has been researched along with Venous Thromboembolism in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Venous Thromboembolism: Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rivaroxaban is a viable anticoagulant for the management of cancer-associated venous thromboembolism (CA-VTE)." | 8.12 | Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug-drug-disease interactions with protein kinase inhibitors in cancer-associated venous thromboembolism. ( Chan, ECY; Cheong, EJY; Chin, SY; Ng, DZW; Wang, Z, 2022) |
| "Rivaroxaban is a viable anticoagulant for the management of cancer-associated venous thromboembolism (CA-VTE)." | 4.12 | Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug-drug-disease interactions with protein kinase inhibitors in cancer-associated venous thromboembolism. ( Chan, ECY; Cheong, EJY; Chin, SY; Ng, DZW; Wang, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, EJY | 1 |
| Ng, DZW | 1 |
| Chin, SY | 1 |
| Wang, Z | 1 |
| Chan, ECY | 1 |
1 other study available for ketoconazole and Venous Thromboembolism
| Article | Year |
|---|---|
Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug-drug-disease interactions with protein kinase inhibitors in cancer-associated venous thromboembolism.
Topics: Cytochrome P-450 CYP3A; Drug Interactions; Erlotinib Hydrochloride; Humans; Ketoconazole; Models, Bi | 2022 |